Showing 1-10 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Genetic dissection of GLP1R signaling in type 1 diabetes outcomes | Yale University | David Alagpulinsa | Improving Lives | 01-April-2026 to 31-March-2027 | $180.829,34 |
| Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes | Yale University | David Alagpulinsa | Cures | 01-April-2026 to 31-March-2027 | $199.959,68 |
| Artificial Intelligence-driven redesign of beta cell regulatory logic for resilience to inflammation | University of Massachusetts Medical School | Rene Maehr | Cures | 01-April-2026 to 31-March-2027 | $199.999,88 |
| Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity | Weill Medical College of Cornell University | Anna Ada Dattoli | Cures | 01-April-2026 to 31-March-2027 | $199.999,32 |
| Building Organotypic Vascularized Pancreatic Islets with Real-Time 4D Tracking of Engraftment and Vascular Maturation | The Regents of the University of California, Los Angeles | Chen Yuan Kam | Cures | 01-April-2026 to 31-March-2027 | $200.000,00 |
| Engineering B Cell–Targeted Microparticles to Induce Regulatory Immunity in Type 1 Diabetes | The University of North Carolina at Chapel Hill | Kristy Ainslie | Cures | 01-April-2026 to 31-March-2027 | $200.000,00 |
| Clinical Translation of NICHE for pancreatic islet transplantation for T1D | Continuity Biosciences | Alessandro Grattoni | Cures | 01-March-2026 to 28-February-2030 | $2.675.316,00 |
| Determining the role of SSTR2 on PRL-2903-mediated glucagon secretion | Trustees of Columbia University in the City of New York | Xiaojuan Chen | Improving Lives | 01-April-2026 to 31-March-2027 | $199.999,39 |
| Cord Blood Proteomic Markers of Type 1 Diabetes Risk: Towards Validation in a Diverse Birth Cohort | University of Florida | Angelica Ahrens | Cures | 01-April-2026 to 31-March-2027 | $199.235,28 |
| Production of SC-islets for distribution | Advanced Regenerative Manufacturing Institute (ARMI) | Thomas Bollenbach | Cures | 01-March-2026 to 30-November-2026 | $471.977,53 |